News Quantified

SLRX – salarius pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Form SC 13G/A Salarius Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC

Form 10-Q Salarius Pharmaceuticals For: Sep 30

Form DEFA14A Salarius Pharmaceuticals

Form DEF 14A Salarius Pharmaceuticals For: Dec 31

Form 8-K Salarius Pharmaceuticals For: Sep 27

Top News Gainers

4/27 Salarius Pharmaceuticals (NASDAQ: SLRX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock. 25.4%

8/26 Ivy Brain Tumor Center and Salarius Pharmaceuticals Launch Collaborative Partnership to Develop New Cancer Treatment for Glioblastoma 21.4%

1/29 Form FWP Salarius Pharmaceuticals Filed by: Salarius Pharmaceuticals, Inc. 20.1%

12/16 Salarius Pharmaceuticals Receives FDA Fast Track Designation for Lead Drug Candidate, Seclidemstat, in Relapsed or Refractory Ewing Sarcoma 13.4%

3/4 Salarius Announces Allowance of New European Patent Covering Seclidemstat 9.2%

3/25 Form 4 Salarius Pharmaceuticals For: Mar 23 Filed by: McCreedy Bruce J Jr. 7.9%

3/2 Salarius Pharmaceuticals to Attend the Oppenheimer Healthcare Conference 7.8%

2/18 Form 4 Salarius Pharmaceuticals For: Feb 18 Filed by: Jordan Scott 6.6%

2/12 Form 8-K Salarius Pharmaceuticals For: Feb 07 4.7%

11/26 Form 4 Salarius Pharmaceuticals For: Nov 25 Filed by: HANISH ARNOLD C 3.6%

Top News Decliners

2/7 Form EFFECT Salarius Pharmaceuticals -58.5%

1/10 Form S-1 Salarius Pharmaceuticals -16.9%

7/29 Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell -16.2%

9/16 Form 8-K Salarius Pharmaceuticals For: Sep 10 -13.6%

9/12 Form 4 Salarius Pharmaceuticals For: Sep 10 Filed by: McVicar William K. -10.8%

1/28 Form S-1/A Salarius Pharmaceuticals -10.6%

2/6 Form S-1/A Salarius Pharmaceuticals -10.4%

7/29 Form SC 13D Salarius Pharmaceuticals Filed by: Sharma Sunil -10.2%

12/17 Salarius Pharmaceuticals Hosting Key Opinion Leader Call on Epigenetics, The Regulatory System That Affects Gene Expression -9.2%

9/12 Salarius Pharmaceuticals Supports Childhood Cancer Awareness Month -9.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day